Table 5.
LV Scar | Distribution | Phenotype | Red Flags | Etiologies | Further Investigation | |
---|---|---|---|---|---|---|
Inferior region | Mid-wall/transmural | HCM | CLINICAL: |
|
Sarcomeric HCM | Genetic testing |
ECG: |
|
|||||
ECHO: |
|
|||||
|
||||||
Mid-wall | NDLVC/DCM | CLINICAL: |
|
Arrhythmic mitral valve prolapse | Rhythm monitoring | |
ECG: |
|
|||||
|
||||||
ECHO: |
|
|||||
Subepicardial/transmural | DCM/HCM | CLINICAL: |
|
Sarcoidosis | Thoracic FDG-PET imaging | |
ECG: |
|
|||||
ECHO: |
|
|||||
|
||||||
|
AV = atrioventricular; DCM = dilated cardiomyopathy; FDG-PET = fluorodeoxyglucose positron emission tomography; HCM = hypertrophic cardiomyopathy; LBBB = left bundle branch block; LVH = left ventricular hypertrophy; MAD = mitral annular disjunction; NDLVC = nondilated left ventricular cardiomyopathy; PH = pulmonary hypertension; PVC = premature ventricular complex; RBBB = right bundle branch block; RV = right ventricular; SAM = systolic anterior motion; SCD = sudden cardiac death; STEMI = ST fluorodeoxyglucose positron emission tomography elevation myocardial infarction.